创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels: Characteristics of Brain In Situ Models

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-08 09:59
  • Views:

(Summary description)Understanding the complex functions of the brain and disease mechanisms has always been a major challenge in neuroscience research. As technology continues to advance, the emergence of Biologically Accurate Brain Models (BAMs) from InnoModels Biotechnology has opened up new avenues for research in this field. Such models provide a powerful tool for neuroscience research with their high degree of simulation and accuracy

InnoModels: Characteristics of Brain In Situ Models

(Summary description)Understanding the complex functions of the brain and disease mechanisms has always been a major challenge in neuroscience research. As technology continues to advance, the emergence of Biologically Accurate Brain Models (BAMs) from InnoModels Biotechnology has opened up new avenues for research in this field. Such models provide a powerful tool for neuroscience research with their high degree of simulation and accuracy

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-08 09:59
  • Views:
Information

Understanding the complex functions of the brain and disease mechanisms has always been a major challenge in neuroscience research. As technology continues to advance, the emergence of Biologically Accurate Brain Models (BAMs) from InnoModels Biotechnology has opened up new avenues for research in this field. Such models provide a powerful tool for neuroscience research with their high degree of simulation and accuracy.
Highly Simulatable
One of the most important features of TInnoModels' in situ brain models is their high degree of simulation. These models are able to simulate the structure and function of the real brain, including the morphology of neurons, synaptic connections, neural network activity, and more. This high degree of simulation allows researchers to conduct more in-depth and systematic studies of the brain in the laboratory without the need for high-risk in vivo experiments.
Controllability
Compared with traditional animal experiments, InnoModels' in situ brain models are highly controllable. Researchers can adjust the parameters and conditions of the model to simulate different physiological and pathological states, thus studying brain functions and disease mechanisms more precisely. This controllability not only improves the accuracy and reliability of experiments, but also provides a more effective experimental platform for drug development and therapeutic approaches.

 


Reproducibility
Another important feature of InnoModels' in situ brain model is its reproducibility. Due to the high simulation and controllability of the model, researchers can repeat the same experiments in different laboratories and over different time periods, thus validating and comparing research results. This reproducibility not only improves the credibility of the research, but also facilitates international cooperation and exchange.
Wide range of application areas
InnoModels' in situ brain model has a wide range of applications in neuroscience research. It can be used to study the normal physiological functions of the brain, such as development, aging, learning and memory, and can also be used to simulate and study various neurological disorders, such as Alzheimer's disease, Parkinson's disease, schizophrenia and so on. In addition, the model can provide an important reference and basis for drug development, selection and optimization of therapeutic methods.
Challenges and Prospects
Despite the many advantages and application prospects of the InnoModels Biotechnology Brain In Situ Model, it still faces some challenges in practical application. For example, the construction and maintenance of the model is costly, technically difficult, and requires specialized knowledge and skills. In addition, due to the complexity and diversity of the brain, it is still a great challenge to fully simulate the function and structure of the real brain.
However, with the continuous advancement of technology and in-depth research, we have reason to believe that the brain in-situ model of InnoModels Biotechnology will play an even more important role in the future. With the continuous development of material science, computer science and biotechnology, we can expect the emergence of more advanced and more accurate models to provide more powerful support for neuroscience research.
In conclusion, as an important tool for neuroscience research, the high simulation, controllability, reproducibility and wide application prospects of the brain in situ model of InnoModels Biotechnology have made it a hotspot and frontier in the current neuroscience research field. With the continuous progress of technology and the expansion of application fields, we have reason to believe that more remarkable results and breakthroughs will be achieved in this field.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司